Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece
Acta Microbiologica et Immunologica Hungarica · 2023
DOI: 10.1556/030.2023.02071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2023. Verfasst von Sofia Maraki und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, Crete, Greece. Hauptthemen laut MEDLINE: Nocardia, Nocardia Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Nocardiosis is a rare disease affecting both immunocompromised and immunocompetent hosts, presented in various clinical forms ranging from localized to disseminated infection. Aim of the present study was to investigate the clinical and microbiological characteristics of nocardiosis, antimicrobial resistance profiles, treatment, and outcomes of Nocardia infection over the last 5 years at our institution. The medical records and microbiological data of patients affected by nocardiosis and treated at the university hospital of Heraklion, Crete, Greece, between 2018 and 2022, were retrospectively analyzed. The isolates were identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and through sequencing of 16S rRNA. Antimicrobial susceptibility for 17 agents was determined by E-test and results were interpreted according to CLSI guidelines. Among the 28 Nocardia isolates, eight species were identified, with Nocardia brasiliensis being the most prevalent (32.1%), followed by Nocardia otitidiscaviarum (25%), and Nocardia farcinica (14.3%). Skin and soft tissue infections were the most common presentations, noted in 13 (50%) patients, followed by pulmonary infection presented in 10 (38.5%) patients. Fifteen patients (57.7%) had at least one underlying disease, and 11 (42.3%) were on immunosuppressive or long-term corticosteroid treatment. Susceptibility rates of linezolid, tigecycline, amikacin, trimethoprim-sulfamethoxazole, moxifloxacin, and imipenem were 100, 100, 96.4, 92.9, 82.1, and 42.9%, respectively. The 26 patients in this study were treated with various antibiotics. Mortality rate was 3.8%, and the patient who died had disseminated infection. Since epidemiology and antimicrobial susceptibility are evolving, continuous surveillance is mandatory in order to initiate appropriate treatment in a timely manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, Crete, Greece.
- 2University of Crete Medical School, Heraklion, Crete, Greece.
- 3Laboratory of Clinical Microbiology and Molecular Microbiology, School of Medicine, University of Crete, Crete, Greece.
ORCID-Profile: Sofia Maraki
Zitieren
APA
Maraki, S., Mavromanolaki, V. E., Kasimati, A., Stafylaki, D., & Scoulica, E. (2023). Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2023.02071
Vancouver
Maraki S, Mavromanolaki VE, Kasimati A, Stafylaki D, Scoulica E. Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece. Acta Microbiologica et Immunologica Hungarica. 2023. doi:10.1556/030.2023.02071
BibTeX
@article{Maraki2023,
author = {Maraki, Sofia and Mavromanolaki, Viktoria Eirini and Kasimati, Anna and Stafylaki, Dimitra and Scoulica, Effie},
title = {Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2023},
doi = {10.1556/030.2023.02071}
}
EUVIMED